|
Finalized Medicare reimbursement pathway for the ReWalk Personal Exoskeleton |
News & Events
Experienced healthcare and rehabilitation technology professional brings more than 30 years of experience in commercialization and new business developmentr all eligible Medicare[...]
Read moreFinalized Medicare reimbursement pathway for personal exoskeletons expands access for all eligible Medicare beneficiaries MARLBOROUGH, MA, and YOKNEAM ILLIT, Israel, April 12, 2024[...]
Read moreBicameral legislation seeks to codify annual examinations and assessments for assistive technologies, including Personal Exoskeletons, for Veterans with Spinal Cord Injury MARLBOROUGH,[...]
Read moreRandomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to a matched[...]
Read moreLifeward brand reflects the Company’s commitment to pioneering innovative technology to empower the pursuit of life’s ambitions in the face of physical[...]
Read moreReWalk Personal Exoskeleton covered as a medically necessary device for an eligible Medicare beneficiary with spinal cord injury MARLBOROUGH, MA, BERLIN, Germany,[...]
Read moreR&D Grant from the Israeli Technology Innovation Consortium Enabled the Successful Demonstration of a Working Prototype MARLBOROUGH, Mass. and BERLIN and YOKNEAM[...]
Read moreVeterans STAND Act mandates regular evaluations of paralyzed Veterans and proactively identifies clinically-eligible Veterans for expedited procurement of personal exoskeletons. MARLBOROUGH, MA,[...]
Read moreMARLBOROUGH, MA, BERLIN, Germany and YOKNEAM ILLIT, Israel, November 6, 2023 – ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a[...]
Read more
© 2024 Lifeward, Inc.
Our mission at Lifeward is to relentlessly drive innovation to change the lives of people with physical limitations or disabilities.
We are committed to delivering groundbreaking solutions that empower individuals to do what they love.